Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,293,854 | 4,397,881 | +104,027 | $80.72M | $81.45M | 53.23% | +$724.3K |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,849,947 | 0 | $38.09M | $36.15M | 23.62% | -$1.94M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 875,000 | 0 | $17.96M | $16.84M | 11.01% | -$1.12M |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 8,325,000 | 0 | $12.07M | $11.49M | 7.51% | -$582.8K |
| Relay Therapeutics, Inc.(RLAY) | 0 | 1,000,000 | +1,000,000 | $0 | $7.08M | 4.63% | +$7.08M |